#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Amyotrophic lateral sclerosis T-cell type acute leukaemia Hypergammaglobulinaemia benign monoclonal Acromegaly Angiosarcoma non-metastatic Pancreatic carcinoma Barth syndrome Immune-mediated renal disorder Prophylaxis against transplant rejection Chronic graft versus host disease in skin Anti-glomerular basement membrane disease Phaeochromocytoma Rhabdomyosarcoma Adenovirus infection Henoch-Schonlein purpura nephritis More trials…

    Learn about Rare Diseases

    Ocular melanoma Mucopolysaccharidosis I – Trials in Disease Congenital generalised lipodystrophy Extranodal marginal zone B-cell lymphoma (MALT type) – Diagnostics Vascular malformation Pleomorphic leiomyosarcoma – Life with Disease Angiosarcoma – Treatment Mantle cell lymphoma stage III Factor VIII deficiency Myxofibrosarcoma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    CARBOMER 980 Gad20-209-Fsp-A4 Adapalene Tetracosactide Abt-494 Abacavir Apadamtase Alfa Camonsertib Tenofovir Alafenamide [89Zr]Bms-986279 Dabigatran Pegenzileukin Tegoprubart Panobinostat Calcium Polystyrene Sulfonate Ravulizumab Selgantolimod Clindamycin Phosphate Isatuximab Albumin More therapies…

    Learn about Your Condition

    Liposarcoma metastatic Milk allergy Toxicity to various agents Intervertebral disc protrusion Coronary artery bypass Death neonatal Diffuse large B-cell lymphoma Laparotomy Thrombosis Angiopathy Pemphigus Binge eating Adenocarcinoma pancreas Ependymoma malignant Nodal osteoarthritis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Non-small cell lung cancer

  • Study on Additional Chemotherapy with Osimertinib, Carboplatin, and Cisplatin for Patients with Advanced Non-Small Cell Lung Cancer and EGFR Mutation

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Osimertinib
    • Carboplatin
    • Cisplatin
    Germany

  • Study on the Effectiveness of Atezolizumab with Radiotherapy for Patients with Metastatic Colorectal, Lung, Renal, and Sarcoma Cancers

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Sarcoma metastatic
    • Renal cancer metastatic
    • Non-small cell lung cancer
    Investigated Drugs:
    • Atezolizumab
    France

  • Study on Datopotamab Deruxtecan and Osimertinib for Patients with Advanced Non-Small Cell Lung Cancer After Osimertinib Treatment

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Osimertinib
    • Carboplatin
    • Cisplatin
    Belgium France Germany Greece Italy Poland +1

  • Study on Durvalumab for Patients with Completely Removed Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Durvalumab
    Bulgaria France Hungary Italy The Netherlands Poland +2

  • Study of Tiragolumab and Atezolizumab for Patients with Advanced Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    • Non-small cell lung cancer metastatic
    Investigated Drugs:
    • Atezolizumab
    • Tiragolumab
    Austria Germany Greece Hungary Italy The Netherlands +2

  • Study of roginolisib, dostarlimab and docetaxel combination for patients with advanced non-small cell lung cancer who did not respond to previous immunotherapy and chemotherapy

    Not recruiting

    1 1 1 1
    Investigated Drugs:
    • Anhydrous Docetaxel
    • Dostarlimab
    • Roginolisib
    Belgium Italy Spain
Previous Page
1 … 51 52 53 54
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!